Oncogenes and Tumor Suppressors DDB 2 Suppresses Tumorigenicity by Limiting the Cancer Stem Cell Population in Ovarian Cancer

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization

  2013cited by this paper
• DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer.

  2013influential reference
• Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

  2013cited by this paper
• Constitutive Activation of Signal Transducer and Activator of Transcription 3 (STAT3) and Nuclear Factor κB Signaling in Glioblastoma Cancer Stem Cells Regulates the Notch Pathway*

  2013cited by this paper
• DDB2: a novel regulator of NF-κB and breast tumor invasion.

  2013influential reference
• NF-κB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype

  2013cited by this paper
• DNA Damage-Binding Complex Recruits HDAC1 to Repress Bcl-2 Transcription in Human Ovarian Cancer Cells

  2013cited by this paper
• Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.

  2012cited by this paper
• Cancer stem cells: an evolving concept

  2012cited by this paper
• Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy

  2012cited by this paper
• The deubiquitinating protein USP24 interacts with DDB2 and regulates DDB2 stability

  2012cited by this paper
• The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

  2012cited by this paper
• p21 Cooperates with DDB2 Protein in Suppression of Ultraviolet Ray-induced Skin Malignancies*

  2011cited by this paper
• Eyes wide open: a critical review of sphere-formation as an assay for stem cells.

  2011cited by this paper
• Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.

  2011cited by this paper
• Integrated Genomic Analyses of Ovarian Carcinoma

  2011cited by this paper
• Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells.

  2011cited by this paper
• A Proteome-wide, Quantitative Survey of In Vivo Ubiquitylation Sites Reveals Widespread Regulatory Roles*

  2011cited by this paper
• Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis

  2010cited by this paper
• The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion.

  2010cited by this paper
• DDB2, an Essential Mediator of Premature Senescence

  2010cited by this paper
• Cancer Stem Cells and Self-renewal

  2010cited by this paper
• CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer

  2009cited by this paper
• DDB2 decides cell fate following DNA damage

  2009cited by this paper
• Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells

  2009cited by this paper
• Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance

  2009cited by this paper
• Identification and characterization of ovarian cancer-initiating cells from primary human tumors.

  2008influential reference
• Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

  2008cited by this paper
• Metastatic cancer stem cells: A new target for anti-cancer therapy?

  2008cited by this paper
• NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells.

  2008cited by this paper
• Ddb2 is a haploinsufficient tumor suppressor and controls spontaneous germ cell apoptosis.

  2007cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• Cancer stem cells: an old idea--a paradigm shift.

  2006cited by this paper
• Clonogenic assay of cells in vitro

  2006cited by this paper
• Cullin 4A-mediated Proteolysis of DDB2 Protein at DNA Damage Sites Regulates in Vivo Lesion Recognition by XPC*

  2006cited by this paper
• Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness.

  2006cited by this paper
• Tumor-prone phenotype of the DDB2-deficient mice

  2005cited by this paper
• Tumour stem cells and drug resistance

  2005cited by this paper
• Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer.

  2005cited by this paper
• NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.

  2004influential reference
• Xeroderma pigmentosum complementation group E and UV-damaged DNA-binding protein.

  2002cited by this paper
• UV-damaged DNA-binding Proteins Are Targets of CUL-4A-mediated Ubiquitination and Degradation*

  2001cited by this paper
• Chromosomal localization and cDNA cloning of the genes (DDB1 and DDB2) for the p127 and p48 subunits of a human damage-specific DNA binding protein.

  1995cited by this paper
• cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.

  1988cited by this paper
• Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.

  1987cited by this paper

• Common deregulated gene expression profiles and morphological changes in developing zebrafish larvae exposed to environmental-relevant high to low concentrations of glucocorticoids.

  2017cites this paper